High Value Online Marketing Industry Poised to Enlist Millions of Users via Social Media

Trouble viewing this email? Click here to see this message online!

Pennexx Foods Inc. (OTC: PNNX) is a Technology Company Operating in the High Value Online Marketing Industry Poised to Enlist Millions of Users via Social Media  ·         Positioned to Capitalize on the Multi-Billion Dollar Social Media Sector. ·         Developing Prepaid Debit Cards Linked to Reward Programs with AI. ·         Highly Experienced Management with New Additions Coming Aboard. ·         Company Offers will Reach Facebook, Pinterest, Twitter, and Other Leading Social Media Platforms. Pennexx Foods, Inc. (OTC: PNNX) is a technology company within the Software / Internet and Fintech industries. Products capitalize on the multibillion-dollar social media market by enabling merchants to use social media to acquire, retain and grow their customer base. YSO users scan a QR code or click a post online, register and share that reward with their friends. PNNX is developing prepaid debit cards which link to its YSO program so rewards can be automatically added. YSO will also leverage artificial intelligence (AI) to optimize and create targeted marketing campaigns. PNNX has acquired BitGift, a company that is creating a unique pre-paid debit card. PNNX utilizes patent pending technology and will be submitting additional patents for example, "A system for monetizing social influence." PNNX earns money through subscription fees, per use charges, transactional fees and contracts with its customers. PNNX is currently poised to reach millions of users through its viral social media approach. PNNX helps businesses grow more efficiently than traditional marketing campaigns. This approach decreases the acquisition cost of acquiring new customers. Customers login through the merchant portal to control their campaigns and view reports on the status of their success. YSO has shown a 96% adoption rate among businesses. ·         Update to Shareholders Regarding the Company’s Strategy, Upcoming Financials and Proposed Changes to the Company’s Board and Guidance for Questions, News and Updates On November 12thPNNX issued a shareholder update. PNNX is building a strong foundation and part of that is building a strong board of directors. CEO Vincent Risalvato is proposing two candidates who have agreed to take a board seat if elected; they are Joseph Caruso and Phillip Welch. Joseph Caruso has a history of startup business success and is a recognized industry leader in the fields of cyber security, computer forensics and eDiscovery. He has been featured as a technology expert regarding high profile cases on CNN Headline News, CBS Evening News with Katie Couric, FOX Business’s Varney and Company. Phillip Welch is a Certified Microsoft Systems Expert, was director of IT for a national broadcast television network and has for nearly 20 years provided managed IT services for hundreds of customers as President and CEO. His background in both technology and the operational aspects of many multi-million-dollar businesses makes him well suited to help guide PNNX to success. PNNX plans include uploading to OTC Markets a formal business plan which include the overall going forward strategy of the company and revenue estimates for the first time. The company will also be outlining its strategy for becoming fully audited. PNNX is on track to achieve the goal of having an audited status. It is an important step to getting the company to a fully reporting SEC status and uplisting. Additionally, PNNX is proposing to change its name by removing the word “Foods” from the name and possibly adding “Technologies”. This name change is in accordance with the fact that PNNX is currently hosting multiple technology projects. PNNX has been having great success with its ongoing development partnership projects including the development of the Cyber Security Dashboard (CSD).  The CSD will begin collecting subscription revenue in the fourth quarter and that profit is shared between PNNX and Global Digital Forensics. Progress on the partnership with Zicix has also been developing well.   PNNX management has indicated that fourth quarter financials will start to show revenue generated through its development partnerships. Since PNNX has just recently launched its new dashboard which opens up a number of revenue generating e-commerce offerings, a small amount of that revenue will also begin in the fourth quarter.  The company should begin to show real quarter over quarter growth from here on into 2021. Additionally, PNNX is still forging forward with its YSO debit card program.    ·         Launch of Your Social Offers Debit Card for the Projected 4.7 Trillion Dollar FinTech Industry and New Version of Merchant Dashboard On August 25th PNNX commented on the launch of its branded prepaid debit card program. The company has been fully approved and finalizing the deployment, such as the graphics for its customized prepaid debit card. These debit cards will allow PNNX (YSO) to credit rewards directly into their users' prepaid debit cards, enabling utilization online or in-store. YSO can then propel into its Social Media Influencer program. With these new prepaid debit cards, the PNNX YSO will offer users a unique and innovative method of being rewarded. YSO can continue to cultivate more clients, as this will open the possibility of real cash rewards for sharing offers on Facebook, Pinterest, Twitter, and other social media platforms. The prepaid debit card will also supercharge YSO's growth through the use of social media influencers. For the first time, social media influencers will be able to 'send' influence directly, post, and share on social media and then immediately receive the payment to their prepaid debit card in a seamless manner. The FinTech market is a rapidly growing industry. According to recent research the global market for prepaid debit cards estimated at the US $2 Trillion in the year 2020, is projected to reach a revised size of US $.1 Trillion by 2027.  Social media influencers reach billions of people; therefore, PNNX believes it will rapidly reach millions of users. PNNX has been developing a range of new features in the latest version of its Your Social Offers merchant dashboard and user portal. The new merchant dashboard will enable users to create a variety of new types of rewards. For more information on Pennexx Foods, Inc. (OTC: PNNX) visit our website here.

Request Removal Here

CURE Pharmaceutical Closes $10 Million Financing

Trouble viewing this email? Click here to see this message online!

Amazing Biotech Stock: CURE Pharmaceutical (OTCQB: CURR) is a Developer of Patented Drug Delivery Tech to Enhance the Effectiveness for a Range of Important Medications. $10 Million Financing Completed to Strongly Expand Global Marketing and Drive Revenue Returns                    ·         FDA-Registered, NSF® and cGMP-Certified Manufacturing Facility. ·         Patented Techniques Improve Efficacy, Safety, and Patient Experience. ·         $10 Million Financing Deal Completed to Expand Marketing Worldwide. ·         Wholly Owned Subsidiary SeraLabs® Introduces Nutri-Strips™, a new Oral Thin Film Strip Technology for Sleep Aid and Immunity Applications. CURE Pharmaceutical (OTCQB: CURR) is a fully integrated and progressive drug delivery company. The CURR team has extensive experience formulating and manufacturing OTC products, pharmaceuticals, and veterinary medications placing quality and service as its top priorities, earning the trust and respect of customers worldwide. CURR is the pioneering developer of CUREform™, a patented drug delivery platform that offers a number of unique immediate-release and controlled-release drug delivery technologies designed to improve drug efficacy, safety, and patient experience for a wide range of active ingredients. CURR delivery technologies include CUREfilm®, an advanced oral thin film; and CUREdrops™, an emulsion technology that can be incorporated into different dosage forms (film, tincture, beverages, etc.), among others. The CURR proprietary clinical pipeline includes CUREfilm®Blue (sildenafil to treat erectile dysfunction), and CUREfilm®Canna (THC and CBD). As a vertically integrated company, CURR operates a 25,000 square foot, FDA-registered, NSF® and cGMP-certified manufacturing facility enabling it to partner with pharmaceutical and wellness companies worldwide for private and white-labeled production. CURR currently has partnerships in the U.S., China, Mexico, Canada, Israel, and other markets in Europe. ·         CURE Pharmaceutical Closes $10 Million Financing On November 2nd CURR announced it had received the first tranche of $4 million in a committed financing of $10 million, after original issue discounts, through the issuance of convertible notes.  Axiom Capital Management, Inc. acted as the sole placement agent in the transaction. CURR may repay the obligations of the notes in cash only, or the notes may be converted upon election of the investor at a fixed price of $1.32 per share subject to certain adjustments. This financing will enable CURR to achieve a number of key company goals and sets the stage for making 2021 a breakout year for the company. CURR has already set in motion the steps needed for progress in two key areas: driving strong sales growth of newly acquired Sera Labs, and advancing its clinical pharmaceutical pipeline, particularly the lead clinical development program for the CURR high value ED treatment, CUREfilm Blue™. ·         Wholly Owned Subsidiary SeraLabs® Introduces Nutri-Strips™, a Revolutionary Oral Thin Film Strip Technology On October 29thCURR announced its wholly owned subsidiary Sera Labs was launching the Nutri-Strips brand with a multi-channel advertising and marketing strategy beginning initially with “Sleep A.S.A.P.™,” which offers a fast-acting, drug-free solution to America’s sleep problem. CURR has developed a broad platform of formulations that offer targeted dosing including patented and advanced oral thin film strip technology, which Sera Labs has branded RAD3 -- for Rapid Activation Delivery and which it is using to deliver novel vitamins and supplements.  CURR Nutri-Strips are administered and activate directly on the tongue, allowing for rapid delivery. This means there is no need for water, chewing or struggling to swallow pills. The strips are formulated by utilizing proprietary organic polymers that trap the active ingredients in a liquid matrix which is then cured into the Nutri-Strips. Millions of American’s have trouble sleeping; according to BCC research, with $52 billion being spent annually on sleep products with Sleep A.S.A.P. as the drug free alternative to sleeping pills. CURR scientists developed this proprietary formulation for sleep by blending five of the most powerful sleep ingredients into one dose to help you get to sleep and stay asleep. CURR is also launching ImmunD3™ to supercharge the immune system (with a once-a-week 40,000IU dose of Vitamin D3), EnergY™ to enhance performance and mental focus, and RecoverB™ for electrolyte and muscle recovery. Additionally, three exciting new line extensions are set to launch in the first quarter of 2021. The brand has already begun an aggressive Q4 digital, print and Sirius radio campaign and will have a national TV broadcast campaign starting Q1 2021 to create the world’s most impactful oral thin strip nutraceutical brand. The company’s recent acquisition by of Sera Labs was fueled largely to help commercialize Nutri-Strip. CURR management expects to see a steep sales trajectory as of a result of its extensive marketing, brand penetration and education campaigns. Now, more than ever consumers are hyper focused on their health and pocketbook and Nutri-Strips solves this problem by offering maximum potency of essential vitamins and supplements while not breaking the bank. The CURR Nutri-Strip line is non-addictive, has no side effects and is created by top formulation scientists. Each strip is hermetically sealed in airtight, grab-and-go packaging to eliminate chemical and structural breakdown and provide superior potency. Most recently, Nutri-Strip was touted at a prominent virtual industry trade show for buyers in retail as the most innovative line in the supplement category seen in years. For more information on CURE Pharmaceutical (OTCQB: CURR) visit our website here.

Request Removal Here

High Value Online Marketing Industry Poised to Enlist Millions of Users via Social Media

Trouble viewing this email? Click here to see this message online!

Pennexx Foods Inc. (OTC: PNNX) is a Technology Company Operating in the High Value Online Marketing Industry Poised to Enlist Millions of Users via Social Media  ·         Positioned to Capitalize on the Multi-Billion Dollar Social Media Sector. ·         Developing Prepaid Debit Cards Linked to Reward Programs with AI. ·         Highly Experienced Management with New Additions Coming Aboard. ·         Company Offers will Reach Facebook, Pinterest, Twitter, and Other Leading Social Media Platforms. Pennexx Foods, Inc. (OTC: PNNX) is a technology company within the Software / Internet and Fintech industries. Products capitalize on the multibillion-dollar social media market by enabling merchants to use social media to acquire, retain and grow their customer base. YSO users scan a QR code or click a post online, register and share that reward with their friends. PNNX is developing prepaid debit cards which link to its YSO program so rewards can be automatically added. YSO will also leverage artificial intelligence (AI) to optimize and create targeted marketing campaigns. PNNX has acquired BitGift, a company that is creating a unique pre-paid debit card. PNNX utilizes patent pending technology and will be submitting additional patents for example, "A system for monetizing social influence." PNNX earns money through subscription fees, per use charges, transactional fees and contracts with its customers. PNNX is currently poised to reach millions of users through its viral social media approach. PNNX helps businesses grow more efficiently than traditional marketing campaigns. This approach decreases the acquisition cost of acquiring new customers. Customers login through the merchant portal to control their campaigns and view reports on the status of their success. YSO has shown a 96% adoption rate among businesses. ·         Update to Shareholders Regarding the Company’s Strategy, Upcoming Financials and Proposed Changes to the Company’s Board and Guidance for Questions, News and Updates On November 12thPNNX issued a shareholder update. PNNX is building a strong foundation and part of that is building a strong board of directors. CEO Vincent Risalvato is proposing two candidates who have agreed to take a board seat if elected; they are Joseph Caruso and Phillip Welch. Joseph Caruso has a history of startup business success and is a recognized industry leader in the fields of cyber security, computer forensics and eDiscovery. He has been featured as a technology expert regarding high profile cases on CNN Headline News, CBS Evening News with Katie Couric, FOX Business’s Varney and Company. Phillip Welch is a Certified Microsoft Systems Expert, was director of IT for a national broadcast television network and has for nearly 20 years provided managed IT services for hundreds of customers as President and CEO. His background in both technology and the operational aspects of many multi-million-dollar businesses makes him well suited to help guide PNNX to success. PNNX plans include uploading to OTC Markets a formal business plan which include the overall going forward strategy of the company and revenue estimates for the first time. The company will also be outlining its strategy for becoming fully audited. PNNX is on track to achieve the goal of having an audited status. It is an important step to getting the company to a fully reporting SEC status and uplisting. Additionally, PNNX is proposing to change its name by removing the word “Foods” from the name and possibly adding “Technologies”. This name change is in accordance with the fact that PNNX is currently hosting multiple technology projects. PNNX has been having great success with its ongoing development partnership projects including the development of the Cyber Security Dashboard (CSD).  The CSD will begin collecting subscription revenue in the fourth quarter and that profit is shared between PNNX and Global Digital Forensics. Progress on the partnership with Zicix has also been developing well.   PNNX management has indicated that fourth quarter financials will start to show revenue generated through its development partnerships. Since PNNX has just recently launched its new dashboard which opens up a number of revenue generating e-commerce offerings, a small amount of that revenue will also begin in the fourth quarter.  The company should begin to show real quarter over quarter growth from here on into 2021. Additionally, PNNX is still forging forward with its YSO debit card program.    ·         Launch of Your Social Offers Debit Card for the Projected 4.7 Trillion Dollar FinTech Industry and New Version of Merchant Dashboard On August 25th PNNX commented on the launch of its branded prepaid debit card program. The company has been fully approved and finalizing the deployment, such as the graphics for its customized prepaid debit card. These debit cards will allow PNNX (YSO) to credit rewards directly into their users' prepaid debit cards, enabling utilization online or in-store. YSO can then propel into its Social Media Influencer program. With these new prepaid debit cards, the PNNX YSO will offer users a unique and innovative method of being rewarded. YSO can continue to cultivate more clients, as this will open the possibility of real cash rewards for sharing offers on Facebook, Pinterest, Twitter, and other social media platforms. The prepaid debit card will also supercharge YSO's growth through the use of social media influencers. For the first time, social media influencers will be able to 'send' influence directly, post, and share on social media and then immediately receive the payment to their prepaid debit card in a seamless manner. The FinTech market is a rapidly growing industry. According to recent research the global market for prepaid debit cards estimated at the US $2 Trillion in the year 2020, is projected to reach a revised size of US $.1 Trillion by 2027.  Social media influencers reach billions of people; therefore, PNNX believes it will rapidly reach millions of users. PNNX has been developing a range of new features in the latest version of its Your Social Offers merchant dashboard and user portal. The new merchant dashboard will enable users to create a variety of new types of rewards. For more information on Pennexx Foods, Inc. (OTC: PNNX) visit our website here.

Request Removal Here

CURE Pharmaceutical Closes $10 Million Financing

Trouble viewing this email? Click here to see this message online!

Amazing Biotech Stock: CURE Pharmaceutical (OTCQB: CURR) is a Developer of Patented Drug Delivery Tech to Enhance the Effectiveness for a Range of Important Medications. $10 Million Financing Completed to Strongly Expand Global Marketing and Drive Revenue Returns                    ·         FDA-Registered, NSF® and cGMP-Certified Manufacturing Facility. ·         Patented Techniques Improve Efficacy, Safety, and Patient Experience. ·         $10 Million Financing Deal Completed to Expand Marketing Worldwide. ·         Wholly Owned Subsidiary SeraLabs® Introduces Nutri-Strips™, a new Oral Thin Film Strip Technology for Sleep Aid and Immunity Applications. CURE Pharmaceutical (OTCQB: CURR) is a fully integrated and progressive drug delivery company. The CURR team has extensive experience formulating and manufacturing OTC products, pharmaceuticals, and veterinary medications placing quality and service as its top priorities, earning the trust and respect of customers worldwide. CURR is the pioneering developer of CUREform™, a patented drug delivery platform that offers a number of unique immediate-release and controlled-release drug delivery technologies designed to improve drug efficacy, safety, and patient experience for a wide range of active ingredients. CURR delivery technologies include CUREfilm®, an advanced oral thin film; and CUREdrops™, an emulsion technology that can be incorporated into different dosage forms (film, tincture, beverages, etc.), among others. The CURR proprietary clinical pipeline includes CUREfilm®Blue (sildenafil to treat erectile dysfunction), and CUREfilm®Canna (THC and CBD). As a vertically integrated company, CURR operates a 25,000 square foot, FDA-registered, NSF® and cGMP-certified manufacturing facility enabling it to partner with pharmaceutical and wellness companies worldwide for private and white-labeled production. CURR currently has partnerships in the U.S., China, Mexico, Canada, Israel, and other markets in Europe. ·         CURE Pharmaceutical Closes $10 Million Financing On November 2nd CURR announced it had received the first tranche of $4 million in a committed financing of $10 million, after original issue discounts, through the issuance of convertible notes.  Axiom Capital Management, Inc. acted as the sole placement agent in the transaction. CURR may repay the obligations of the notes in cash only, or the notes may be converted upon election of the investor at a fixed price of $1.32 per share subject to certain adjustments. This financing will enable CURR to achieve a number of key company goals and sets the stage for making 2021 a breakout year for the company. CURR has already set in motion the steps needed for progress in two key areas: driving strong sales growth of newly acquired Sera Labs, and advancing its clinical pharmaceutical pipeline, particularly the lead clinical development program for the CURR high value ED treatment, CUREfilm Blue™. ·         Wholly Owned Subsidiary SeraLabs® Introduces Nutri-Strips™, a Revolutionary Oral Thin Film Strip Technology On October 29thCURR announced its wholly owned subsidiary Sera Labs was launching the Nutri-Strips brand with a multi-channel advertising and marketing strategy beginning initially with “Sleep A.S.A.P.™,” which offers a fast-acting, drug-free solution to America’s sleep problem. CURR has developed a broad platform of formulations that offer targeted dosing including patented and advanced oral thin film strip technology, which Sera Labs has branded RAD3 -- for Rapid Activation Delivery and which it is using to deliver novel vitamins and supplements.  CURR Nutri-Strips are administered and activate directly on the tongue, allowing for rapid delivery. This means there is no need for water, chewing or struggling to swallow pills. The strips are formulated by utilizing proprietary organic polymers that trap the active ingredients in a liquid matrix which is then cured into the Nutri-Strips. Millions of American’s have trouble sleeping; according to BCC research, with $52 billion being spent annually on sleep products with Sleep A.S.A.P. as the drug free alternative to sleeping pills. CURR scientists developed this proprietary formulation for sleep by blending five of the most powerful sleep ingredients into one dose to help you get to sleep and stay asleep. CURR is also launching ImmunD3™ to supercharge the immune system (with a once-a-week 40,000IU dose of Vitamin D3), EnergY™ to enhance performance and mental focus, and RecoverB™ for electrolyte and muscle recovery. Additionally, three exciting new line extensions are set to launch in the first quarter of 2021. The brand has already begun an aggressive Q4 digital, print and Sirius radio campaign and will have a national TV broadcast campaign starting Q1 2021 to create the world’s most impactful oral thin strip nutraceutical brand. The company’s recent acquisition by of Sera Labs was fueled largely to help commercialize Nutri-Strip. CURR management expects to see a steep sales trajectory as of a result of its extensive marketing, brand penetration and education campaigns. Now, more than ever consumers are hyper focused on their health and pocketbook and Nutri-Strips solves this problem by offering maximum potency of essential vitamins and supplements while not breaking the bank. The CURR Nutri-Strip line is non-addictive, has no side effects and is created by top formulation scientists. Each strip is hermetically sealed in airtight, grab-and-go packaging to eliminate chemical and structural breakdown and provide superior potency. Most recently, Nutri-Strip was touted at a prominent virtual industry trade show for buyers in retail as the most innovative line in the supplement category seen in years. For more information on CURE Pharmaceutical (OTCQB: CURR) visit our website here.

Request Removal Here

High Value Online Marketing Industry Poised to Enlist Millions of Users via Social Media

Trouble viewing this email? Click here to see this message online!

Pennexx Foods Inc. (OTC: PNNX) is a Technology Company Operating in the High Value Online Marketing Industry Poised to Enlist Millions of Users via Social Media  ·         Positioned to Capitalize on the Multi-Billion Dollar Social Media Sector. ·         Developing Prepaid Debit Cards Linked to Reward Programs with AI. ·         Highly Experienced Management with New Additions Coming Aboard. ·         Company Offers will Reach Facebook, Pinterest, Twitter, and Other Leading Social Media Platforms. Pennexx Foods, Inc. (OTC: PNNX) is a technology company within the Software / Internet and Fintech industries. Products capitalize on the multibillion-dollar social media market by enabling merchants to use social media to acquire, retain and grow their customer base. YSO users scan a QR code or click a post online, register and share that reward with their friends. PNNX is developing prepaid debit cards which link to its YSO program so rewards can be automatically added. YSO will also leverage artificial intelligence (AI) to optimize and create targeted marketing campaigns. PNNX has acquired BitGift, a company that is creating a unique pre-paid debit card. PNNX utilizes patent pending technology and will be submitting additional patents for example, "A system for monetizing social influence." PNNX earns money through subscription fees, per use charges, transactional fees and contracts with its customers. PNNX is currently poised to reach millions of users through its viral social media approach. PNNX helps businesses grow more efficiently than traditional marketing campaigns. This approach decreases the acquisition cost of acquiring new customers. Customers login through the merchant portal to control their campaigns and view reports on the status of their success. YSO has shown a 96% adoption rate among businesses. ·         Update to Shareholders Regarding the Company’s Strategy, Upcoming Financials and Proposed Changes to the Company’s Board and Guidance for Questions, News and Updates On November 12thPNNX issued a shareholder update. PNNX is building a strong foundation and part of that is building a strong board of directors. CEO Vincent Risalvato is proposing two candidates who have agreed to take a board seat if elected; they are Joseph Caruso and Phillip Welch. Joseph Caruso has a history of startup business success and is a recognized industry leader in the fields of cyber security, computer forensics and eDiscovery. He has been featured as a technology expert regarding high profile cases on CNN Headline News, CBS Evening News with Katie Couric, FOX Business’s Varney and Company. Phillip Welch is a Certified Microsoft Systems Expert, was director of IT for a national broadcast television network and has for nearly 20 years provided managed IT services for hundreds of customers as President and CEO. His background in both technology and the operational aspects of many multi-million-dollar businesses makes him well suited to help guide PNNX to success. PNNX plans include uploading to OTC Markets a formal business plan which include the overall going forward strategy of the company and revenue estimates for the first time. The company will also be outlining its strategy for becoming fully audited. PNNX is on track to achieve the goal of having an audited status. It is an important step to getting the company to a fully reporting SEC status and uplisting. Additionally, PNNX is proposing to change its name by removing the word “Foods” from the name and possibly adding “Technologies”. This name change is in accordance with the fact that PNNX is currently hosting multiple technology projects. PNNX has been having great success with its ongoing development partnership projects including the development of the Cyber Security Dashboard (CSD).  The CSD will begin collecting subscription revenue in the fourth quarter and that profit is shared between PNNX and Global Digital Forensics. Progress on the partnership with Zicix has also been developing well.   PNNX management has indicated that fourth quarter financials will start to show revenue generated through its development partnerships. Since PNNX has just recently launched its new dashboard which opens up a number of revenue generating e-commerce offerings, a small amount of that revenue will also begin in the fourth quarter.  The company should begin to show real quarter over quarter growth from here on into 2021. Additionally, PNNX is still forging forward with its YSO debit card program.    ·         Launch of Your Social Offers Debit Card for the Projected 4.7 Trillion Dollar FinTech Industry and New Version of Merchant Dashboard On August 25th PNNX commented on the launch of its branded prepaid debit card program. The company has been fully approved and finalizing the deployment, such as the graphics for its customized prepaid debit card. These debit cards will allow PNNX (YSO) to credit rewards directly into their users' prepaid debit cards, enabling utilization online or in-store. YSO can then propel into its Social Media Influencer program. With these new prepaid debit cards, the PNNX YSO will offer users a unique and innovative method of being rewarded. YSO can continue to cultivate more clients, as this will open the possibility of real cash rewards for sharing offers on Facebook, Pinterest, Twitter, and other social media platforms. The prepaid debit card will also supercharge YSO's growth through the use of social media influencers. For the first time, social media influencers will be able to 'send' influence directly, post, and share on social media and then immediately receive the payment to their prepaid debit card in a seamless manner. The FinTech market is a rapidly growing industry. According to recent research the global market for prepaid debit cards estimated at the US $2 Trillion in the year 2020, is projected to reach a revised size of US $.1 Trillion by 2027.  Social media influencers reach billions of people; therefore, PNNX believes it will rapidly reach millions of users. PNNX has been developing a range of new features in the latest version of its Your Social Offers merchant dashboard and user portal. The new merchant dashboard will enable users to create a variety of new types of rewards. For more information on Pennexx Foods, Inc. (OTC: PNNX) visit our website here.

Request Removal Here

CURE Pharmaceutical Closes $10 Million Financing

Trouble viewing this email? Click here to see this message online!

Amazing Biotech Stock: CURE Pharmaceutical (OTCQB: CURR) is a Developer of Patented Drug Delivery Tech to Enhance the Effectiveness for a Range of Important Medications. $10 Million Financing Completed to Strongly Expand Global Marketing and Drive Revenue Returns                    ·         FDA-Registered, NSF® and cGMP-Certified Manufacturing Facility. ·         Patented Techniques Improve Efficacy, Safety, and Patient Experience. ·         $10 Million Financing Deal Completed to Expand Marketing Worldwide. ·         Wholly Owned Subsidiary SeraLabs® Introduces Nutri-Strips™, a new Oral Thin Film Strip Technology for Sleep Aid and Immunity Applications. CURE Pharmaceutical (OTCQB: CURR) is a fully integrated and progressive drug delivery company. The CURR team has extensive experience formulating and manufacturing OTC products, pharmaceuticals, and veterinary medications placing quality and service as its top priorities, earning the trust and respect of customers worldwide. CURR is the pioneering developer of CUREform™, a patented drug delivery platform that offers a number of unique immediate-release and controlled-release drug delivery technologies designed to improve drug efficacy, safety, and patient experience for a wide range of active ingredients. CURR delivery technologies include CUREfilm®, an advanced oral thin film; and CUREdrops™, an emulsion technology that can be incorporated into different dosage forms (film, tincture, beverages, etc.), among others. The CURR proprietary clinical pipeline includes CUREfilm®Blue (sildenafil to treat erectile dysfunction), and CUREfilm®Canna (THC and CBD). As a vertically integrated company, CURR operates a 25,000 square foot, FDA-registered, NSF® and cGMP-certified manufacturing facility enabling it to partner with pharmaceutical and wellness companies worldwide for private and white-labeled production. CURR currently has partnerships in the U.S., China, Mexico, Canada, Israel, and other markets in Europe. ·         CURE Pharmaceutical Closes $10 Million Financing On November 2nd CURR announced it had received the first tranche of $4 million in a committed financing of $10 million, after original issue discounts, through the issuance of convertible notes.  Axiom Capital Management, Inc. acted as the sole placement agent in the transaction. CURR may repay the obligations of the notes in cash only, or the notes may be converted upon election of the investor at a fixed price of $1.32 per share subject to certain adjustments. This financing will enable CURR to achieve a number of key company goals and sets the stage for making 2021 a breakout year for the company. CURR has already set in motion the steps needed for progress in two key areas: driving strong sales growth of newly acquired Sera Labs, and advancing its clinical pharmaceutical pipeline, particularly the lead clinical development program for the CURR high value ED treatment, CUREfilm Blue™. ·         Wholly Owned Subsidiary SeraLabs® Introduces Nutri-Strips™, a Revolutionary Oral Thin Film Strip Technology On October 29thCURR announced its wholly owned subsidiary Sera Labs was launching the Nutri-Strips brand with a multi-channel advertising and marketing strategy beginning initially with “Sleep A.S.A.P.™,” which offers a fast-acting, drug-free solution to America’s sleep problem. CURR has developed a broad platform of formulations that offer targeted dosing including patented and advanced oral thin film strip technology, which Sera Labs has branded RAD3 -- for Rapid Activation Delivery and which it is using to deliver novel vitamins and supplements.  CURR Nutri-Strips are administered and activate directly on the tongue, allowing for rapid delivery. This means there is no need for water, chewing or struggling to swallow pills. The strips are formulated by utilizing proprietary organic polymers that trap the active ingredients in a liquid matrix which is then cured into the Nutri-Strips. Millions of American’s have trouble sleeping; according to BCC research, with $52 billion being spent annually on sleep products with Sleep A.S.A.P. as the drug free alternative to sleeping pills. CURR scientists developed this proprietary formulation for sleep by blending five of the most powerful sleep ingredients into one dose to help you get to sleep and stay asleep. CURR is also launching ImmunD3™ to supercharge the immune system (with a once-a-week 40,000IU dose of Vitamin D3), EnergY™ to enhance performance and mental focus, and RecoverB™ for electrolyte and muscle recovery. Additionally, three exciting new line extensions are set to launch in the first quarter of 2021. The brand has already begun an aggressive Q4 digital, print and Sirius radio campaign and will have a national TV broadcast campaign starting Q1 2021 to create the world’s most impactful oral thin strip nutraceutical brand. The company’s recent acquisition by of Sera Labs was fueled largely to help commercialize Nutri-Strip. CURR management expects to see a steep sales trajectory as of a result of its extensive marketing, brand penetration and education campaigns. Now, more than ever consumers are hyper focused on their health and pocketbook and Nutri-Strips solves this problem by offering maximum potency of essential vitamins and supplements while not breaking the bank. The CURR Nutri-Strip line is non-addictive, has no side effects and is created by top formulation scientists. Each strip is hermetically sealed in airtight, grab-and-go packaging to eliminate chemical and structural breakdown and provide superior potency. Most recently, Nutri-Strip was touted at a prominent virtual industry trade show for buyers in retail as the most innovative line in the supplement category seen in years. For more information on CURE Pharmaceutical (OTCQB: CURR) visit our website here.

Request Removal Here

High Value Online Marketing Industry Poised to Enlist Millions of Users via Social Media

Trouble viewing this email? Click here to see this message online!

Pennexx Foods Inc. (OTC: PNNX) is a Technology Company Operating in the High Value Online Marketing Industry Poised to Enlist Millions of Users via Social Media  ·         Positioned to Capitalize on the Multi-Billion Dollar Social Media Sector. ·         Developing Prepaid Debit Cards Linked to Reward Programs with AI. ·         Highly Experienced Management with New Additions Coming Aboard. ·         Company Offers will Reach Facebook, Pinterest, Twitter, and Other Leading Social Media Platforms. Pennexx Foods, Inc. (OTC: PNNX) is a technology company within the Software / Internet and Fintech industries. Products capitalize on the multibillion-dollar social media market by enabling merchants to use social media to acquire, retain and grow their customer base. YSO users scan a QR code or click a post online, register and share that reward with their friends. PNNX is developing prepaid debit cards which link to its YSO program so rewards can be automatically added. YSO will also leverage artificial intelligence (AI) to optimize and create targeted marketing campaigns. PNNX has acquired BitGift, a company that is creating a unique pre-paid debit card. PNNX utilizes patent pending technology and will be submitting additional patents for example, "A system for monetizing social influence." PNNX earns money through subscription fees, per use charges, transactional fees and contracts with its customers. PNNX is currently poised to reach millions of users through its viral social media approach. PNNX helps businesses grow more efficiently than traditional marketing campaigns. This approach decreases the acquisition cost of acquiring new customers. Customers login through the merchant portal to control their campaigns and view reports on the status of their success. YSO has shown a 96% adoption rate among businesses. ·         Update to Shareholders Regarding the Company’s Strategy, Upcoming Financials and Proposed Changes to the Company’s Board and Guidance for Questions, News and Updates On November 12thPNNX issued a shareholder update. PNNX is building a strong foundation and part of that is building a strong board of directors. CEO Vincent Risalvato is proposing two candidates who have agreed to take a board seat if elected; they are Joseph Caruso and Phillip Welch. Joseph Caruso has a history of startup business success and is a recognized industry leader in the fields of cyber security, computer forensics and eDiscovery. He has been featured as a technology expert regarding high profile cases on CNN Headline News, CBS Evening News with Katie Couric, FOX Business’s Varney and Company. Phillip Welch is a Certified Microsoft Systems Expert, was director of IT for a national broadcast television network and has for nearly 20 years provided managed IT services for hundreds of customers as President and CEO. His background in both technology and the operational aspects of many multi-million-dollar businesses makes him well suited to help guide PNNX to success. PNNX plans include uploading to OTC Markets a formal business plan which include the overall going forward strategy of the company and revenue estimates for the first time. The company will also be outlining its strategy for becoming fully audited. PNNX is on track to achieve the goal of having an audited status. It is an important step to getting the company to a fully reporting SEC status and uplisting. Additionally, PNNX is proposing to change its name by removing the word “Foods” from the name and possibly adding “Technologies”. This name change is in accordance with the fact that PNNX is currently hosting multiple technology projects. PNNX has been having great success with its ongoing development partnership projects including the development of the Cyber Security Dashboard (CSD).  The CSD will begin collecting subscription revenue in the fourth quarter and that profit is shared between PNNX and Global Digital Forensics. Progress on the partnership with Zicix has also been developing well.   PNNX management has indicated that fourth quarter financials will start to show revenue generated through its development partnerships. Since PNNX has just recently launched its new dashboard which opens up a number of revenue generating e-commerce offerings, a small amount of that revenue will also begin in the fourth quarter.  The company should begin to show real quarter over quarter growth from here on into 2021. Additionally, PNNX is still forging forward with its YSO debit card program.    ·         Launch of Your Social Offers Debit Card for the Projected 4.7 Trillion Dollar FinTech Industry and New Version of Merchant Dashboard On August 25th PNNX commented on the launch of its branded prepaid debit card program. The company has been fully approved and finalizing the deployment, such as the graphics for its customized prepaid debit card. These debit cards will allow PNNX (YSO) to credit rewards directly into their users' prepaid debit cards, enabling utilization online or in-store. YSO can then propel into its Social Media Influencer program. With these new prepaid debit cards, the PNNX YSO will offer users a unique and innovative method of being rewarded. YSO can continue to cultivate more clients, as this will open the possibility of real cash rewards for sharing offers on Facebook, Pinterest, Twitter, and other social media platforms. The prepaid debit card will also supercharge YSO's growth through the use of social media influencers. For the first time, social media influencers will be able to 'send' influence directly, post, and share on social media and then immediately receive the payment to their prepaid debit card in a seamless manner. The FinTech market is a rapidly growing industry. According to recent research the global market for prepaid debit cards estimated at the US $2 Trillion in the year 2020, is projected to reach a revised size of US $.1 Trillion by 2027.  Social media influencers reach billions of people; therefore, PNNX believes it will rapidly reach millions of users. PNNX has been developing a range of new features in the latest version of its Your Social Offers merchant dashboard and user portal. The new merchant dashboard will enable users to create a variety of new types of rewards. For more information on Pennexx Foods, Inc. (OTC: PNNX) visit our website here.

Request Removal Here

CURE Pharmaceutical Closes $10 Million Financing

Trouble viewing this email? Click here to see this message online!

Amazing Biotech Stock: CURE Pharmaceutical (OTCQB: CURR) is a Developer of Patented Drug Delivery Tech to Enhance the Effectiveness for a Range of Important Medications. $10 Million Financing Completed to Strongly Expand Global Marketing and Drive Revenue Returns                    ·         FDA-Registered, NSF® and cGMP-Certified Manufacturing Facility. ·         Patented Techniques Improve Efficacy, Safety, and Patient Experience. ·         $10 Million Financing Deal Completed to Expand Marketing Worldwide. ·         Wholly Owned Subsidiary SeraLabs® Introduces Nutri-Strips™, a new Oral Thin Film Strip Technology for Sleep Aid and Immunity Applications. CURE Pharmaceutical (OTCQB: CURR) is a fully integrated and progressive drug delivery company. The CURR team has extensive experience formulating and manufacturing OTC products, pharmaceuticals, and veterinary medications placing quality and service as its top priorities, earning the trust and respect of customers worldwide. CURR is the pioneering developer of CUREform™, a patented drug delivery platform that offers a number of unique immediate-release and controlled-release drug delivery technologies designed to improve drug efficacy, safety, and patient experience for a wide range of active ingredients. CURR delivery technologies include CUREfilm®, an advanced oral thin film; and CUREdrops™, an emulsion technology that can be incorporated into different dosage forms (film, tincture, beverages, etc.), among others. The CURR proprietary clinical pipeline includes CUREfilm®Blue (sildenafil to treat erectile dysfunction), and CUREfilm®Canna (THC and CBD). As a vertically integrated company, CURR operates a 25,000 square foot, FDA-registered, NSF® and cGMP-certified manufacturing facility enabling it to partner with pharmaceutical and wellness companies worldwide for private and white-labeled production. CURR currently has partnerships in the U.S., China, Mexico, Canada, Israel, and other markets in Europe. ·         CURE Pharmaceutical Closes $10 Million Financing On November 2nd CURR announced it had received the first tranche of $4 million in a committed financing of $10 million, after original issue discounts, through the issuance of convertible notes.  Axiom Capital Management, Inc. acted as the sole placement agent in the transaction. CURR may repay the obligations of the notes in cash only, or the notes may be converted upon election of the investor at a fixed price of $1.32 per share subject to certain adjustments. This financing will enable CURR to achieve a number of key company goals and sets the stage for making 2021 a breakout year for the company. CURR has already set in motion the steps needed for progress in two key areas: driving strong sales growth of newly acquired Sera Labs, and advancing its clinical pharmaceutical pipeline, particularly the lead clinical development program for the CURR high value ED treatment, CUREfilm Blue™. ·         Wholly Owned Subsidiary SeraLabs® Introduces Nutri-Strips™, a Revolutionary Oral Thin Film Strip Technology On October 29thCURR announced its wholly owned subsidiary Sera Labs was launching the Nutri-Strips brand with a multi-channel advertising and marketing strategy beginning initially with “Sleep A.S.A.P.™,” which offers a fast-acting, drug-free solution to America’s sleep problem. CURR has developed a broad platform of formulations that offer targeted dosing including patented and advanced oral thin film strip technology, which Sera Labs has branded RAD3 -- for Rapid Activation Delivery and which it is using to deliver novel vitamins and supplements.  CURR Nutri-Strips are administered and activate directly on the tongue, allowing for rapid delivery. This means there is no need for water, chewing or struggling to swallow pills. The strips are formulated by utilizing proprietary organic polymers that trap the active ingredients in a liquid matrix which is then cured into the Nutri-Strips. Millions of American’s have trouble sleeping; according to BCC research, with $52 billion being spent annually on sleep products with Sleep A.S.A.P. as the drug free alternative to sleeping pills. CURR scientists developed this proprietary formulation for sleep by blending five of the most powerful sleep ingredients into one dose to help you get to sleep and stay asleep. CURR is also launching ImmunD3™ to supercharge the immune system (with a once-a-week 40,000IU dose of Vitamin D3), EnergY™ to enhance performance and mental focus, and RecoverB™ for electrolyte and muscle recovery. Additionally, three exciting new line extensions are set to launch in the first quarter of 2021. The brand has already begun an aggressive Q4 digital, print and Sirius radio campaign and will have a national TV broadcast campaign starting Q1 2021 to create the world’s most impactful oral thin strip nutraceutical brand. The company’s recent acquisition by of Sera Labs was fueled largely to help commercialize Nutri-Strip. CURR management expects to see a steep sales trajectory as of a result of its extensive marketing, brand penetration and education campaigns. Now, more than ever consumers are hyper focused on their health and pocketbook and Nutri-Strips solves this problem by offering maximum potency of essential vitamins and supplements while not breaking the bank. The CURR Nutri-Strip line is non-addictive, has no side effects and is created by top formulation scientists. Each strip is hermetically sealed in airtight, grab-and-go packaging to eliminate chemical and structural breakdown and provide superior potency. Most recently, Nutri-Strip was touted at a prominent virtual industry trade show for buyers in retail as the most innovative line in the supplement category seen in years. For more information on CURE Pharmaceutical (OTCQB: CURR) visit our website here.

Request Removal Here